Completed
Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling
What is being collected
Data Collection
Collected from past medical records and data - RetrospectiveDNA Samples
Who is being recruted
Digestive System Diseases+2
+ Gastroenteritis
+ Gastrointestinal Diseases
Over 18 Years
+4 Eligibility Criteria
How is the trial designed
Case-Control
Comparing exposures between individuals with and without disease in order to identify potential risk factors.Observational
Study Start: August 2008
Summary
Principal SponsorKU Leuven
Last updated: August 17, 2012
Sourced from a government-validated database.Claim as a partner
Study start date: August 1, 2008
Actual date on which the first participant was enrolled.The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel Disease(IBD) patients versus healthy controls (HC).
Principal SponsorKU Leuven
Last updated: August 17, 2012
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
204 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-Control
These studies compare people who have a disease (cases) with those who don't (controls). The goal is to look back at previous exposures or risk factors to identify what might have contributed to the disease.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Digestive System DiseasesGastroenteritisGastrointestinal DiseasesIntestinal DiseasesInflammatory Bowel Diseases
Criteria
2 inclusion criteria required to participate
Age > 18 years
Clinical diagnosis of IBD
2 exclusion criteria prevent from participating
Intake of pre- or probiotics
Use of antibiotics in the preceding month
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
CompletedOne Study Center